Hervé Tilly

Also affiliated with Laboratoire National Henri Becquerel, Centre Virchow-Villermé, Centre Henri Becquerel, Génomique du cancer et du cerveau, Université de Rouen Normandie

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma”.

Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology(2025)10.1200/jco-25-00925

N/A

0.520DataRank · unranked

31 citations

Gilles Salles, Laurie H. Sehn, Alex F. Herrera, Jonathan W. Friedberg, Marek Trněný +32 more

Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas

Blood Reviews(2022)10.1016/j.blre.2022.100988

N/A

0.477DataRank · unranked

23 citations

Gilles Salles, Connie Lee Batlevi, Hervé Tilly, Aristeidis Chaidos, Tycel Phillips +3 more

Evaluation of Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Findings from the Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 7507 Patients

Blood(2016)10.1182/blood.v128.22.4196.4196

N/A

0.208DataRank · unranked

3 citations

Norbert Schmitz, Christopher Flowers, Fang-Shu Ou, David Cunningham, Michael Pfreundschuh +14 more

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

UNC Libraries(2020)10.17615/y5gv-3561

N/A

0DataRank · unranked

0 citations

Anneclaire J. De Roos, Brian K. Link, Anne J. Novak, Yuanqing Ye, Mitchell J. Machiela +95 more

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma

American Journal of Hematology(2021)10.1002/ajh.26149

N/A

0DataRank · unranked

22 citations

Lasse Hjort Jakobsen, Raphael Mwangi, Norbert Schmitz, Umar Farooq, C. R. Flowers +18 more

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

Journal of Clinical Oncology(2025)10.1200/jco-25-00892

N/A

0DataRank · unranked

1 citations

Vít Procházka, Tarec Christoffer El‐Galaly, Christopher R. Flowers, Diego Villa, Emmanuel Bachy +43 more